Dyne Therapeutics, Inc. (DYN) › Operating IncomeDyne Therapeutics, Inc. (DYN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$13.83M2020: -$58.65M2021: -$150.03M2022: -$170.96M2023: -$242.16M2024: -$343.89M2025: -$468.18M-$468.18M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$468.18M-36.1%2024-$343.89M-42.0%2023-$242.16M-41.6%2022-$170.96M-14.0%2021-$150.03M-155.8%2020-$58.65M-324.2%2019-$13.83M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share